BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6975717)

  • 41. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.
    Scharenberg JG; Rijkers GT; Akkerman JW; Staal GE; Zegers BJ
    Int J Immunopharmacol; 1990; 12(1):113-20. PubMed ID: 2303314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ADA deficiency on cultured murine thymus transplantation.
    Hong R; Horowitz SD; Fortman C; Martin DW
    Clin Immunol Immunopathol; 1982 May; 23(2):448-58. PubMed ID: 6980759
    [No Abstract]   [Full Text] [Related]  

  • 43. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purine deoxynucleosides and adenosine dialdehyde decrease 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis in cultured T and B lymphoblasts.
    Boss GR
    Biochem J; 1987 Mar; 242(2):425-31. PubMed ID: 3109390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of lymphoid cell growth by adenine ribonucleotide accumulation. The role of phosphoribosylpyrophosphate-depletion induced pyrimidine starvation.
    van der Kraan PM; van Zandvoort PM; De Abreu RA; van Baal JM; Bakkeren JA
    Biochim Biophys Acta; 1987 Feb; 927(2):213-21. PubMed ID: 2434139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
    Matsumoto SS; Yu J; Yu AL
    J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
    Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
    J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
    Coleman MS; Danton MJ; Philips A
    Ann N Y Acad Sci; 1985; 451():54-65. PubMed ID: 3878121
    [No Abstract]   [Full Text] [Related]  

  • 49. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
    Franco R; Hoyle CH; Centelles JJ; Burnstock G
    Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF; Fox RM
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation.
    Buc HA; Moncion A; Hamet M; Houllier AM; Thuilier L; Perignon JL
    Eur J Immunol; 1990 Mar; 20(3):611-5. PubMed ID: 2156710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
    Siaw MF; Coleman MS
    J Biol Chem; 1984 Aug; 259(15):9426-33. PubMed ID: 6204981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
    Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ
    Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine- and deoxyadenosine-mediated altered pyrimidine metabolism in human adeosine deaminase-deficient lymphoblasts.
    Parker NF; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1982 May; 99(5):731-9. PubMed ID: 6175708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consequences of the salvage of purine compounds on the proliferation of rat T-lymphocytes with normal or inhibited purine de novo synthesis.
    Thuillier L; Perignon JL; Houllier AM; Munier A; Cartier P
    Biochim Biophys Acta; 1984 Apr; 798(3):343-9. PubMed ID: 6424727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
    Ballow M; Pantschenko AG
    Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

  • 58. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
    Kubota M; Carrera CJ; Wasson DB; Carson DA
    Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation of mutant adenosine deaminase by coformycin affinity chromatography.
    Danton MJ; Coleman MS
    Anal Biochem; 1986 Nov; 159(1):233-9. PubMed ID: 3492941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors.
    Wakade AR; Przywara DA; Palmer KC; Kulkarni JS; Wakade TD
    J Biol Chem; 1995 Jul; 270(30):17986-92. PubMed ID: 7629106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.